Biofrontera AG Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 19, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	16	13	26	97	84	146
Market Cap Growth	14.96%	-48.94%	-73.70%	15.92%	-42.36%	-29.41%
Enterprise Value	13	12	25	99	76	160
Last Close Price	2.52	2.09	8.61	30.56	30.44	57.65
PE Ratio	-	-	-	-	2.19	-
PS Ratio	0.70	0.60	0.79	3.78	2.92	4.80
PB Ratio	1.10	0.69	1.28	4.79	1.45	19.75
P/TBV Ratio	1.10	0.73	1.36	5.08	1.48	-
P/FCF Ratio	-	-	-	-	2.82	-
P/OCF Ratio	-	-	-	-	2.76	-
EV/Sales Ratio	0.58	0.56	0.77	3.86	2.63	5.27
EV/EBITDA Ratio	44.19	-	4.95	55.91	-	-
EV/EBIT Ratio	-	-	5.17	62.48	-	-
EV/FCF Ratio	-	-	-	-	2.54	-
Debt / Equity Ratio	0.04	0.04	0.06	0.07	0.06	3.24
Debt / EBITDA Ratio	1.21	-	0.21	0.68	-	-
Debt / FCF Ratio	-	-	-	-	0.11	-
Net Debt / Equity Ratio	-0.20	-0.12	-0.10	-0.24	-0.06	0.99
Net Debt / EBITDA Ratio	11696.00	0.41	-0.39	-2.74	0.23	-1.37
Net Debt / FCF Ratio	-	0.86	0.69	1.00	-0.12	-2.02
Asset Turnover	1.09	0.72	1.02	0.47	0.43	0.53
Inventory Turnover	1.20	1.00	1.26	0.99	0.83	0.81
Quick Ratio	1.13	0.92	1.08	1.02	0.48	2.42
Current Ratio	2.91	1.55	1.76	1.80	0.82	3.15
Return on Equity (ROE)	-13.47%	-22.40%	-1.83%	-112.77%	103.58%	-150.29%
Return on Assets (ROA)	-0.77%	-12.30%	9.42%	1.82%	-14.92%	-6.11%
Return on Invested Capital (ROIC)	6.43%	-34.40%	28.54%	4.55%	-43.62%	-30.44%
Return on Capital Employed (ROCE)	-1.80%	-31.00%	23.10%	6.50%	-26.80%	-11.70%
Earnings Yield	-13.09%	-33.29%	-1.44%	-45.39%	45.65%	-8.94%
FCF Yield	-	-21.04%	-11.01%	-5.01%	35.51%	-2.49%
Buyback Yield / Dilution	-104.99%	-100.00%	-11.02%	-1.34%	-4.68%	-21.23%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.